ALCAM and lobular neoplasia: In this study, we have set the foundation for building a portable at-home detection device to noninvasively assess lupus nephritis activity: a highly sensitive LFA coupled with smartphone-based time-gated imaging to detect urine CD166/ALCAM, a leading biomarker for LN.